drugset / Trial / NCT00253110
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to compare the time to relapse in patients with schizophrenia and schizoaffective disorders receiving risperidone or haloperidol (antipsychotic medications) for at least 1 year.
Timeline
- Start
- 1996-05
- Primary completion
- —
- Completion
- 1998-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 10 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 4 mg | Oral |